UBS upgraded Morgan Stanley's rating from Neutral to Buy, citing the firm's strong profitability, growth potential, and leadership in wealth management despite market uncertainties. The analysts set a 12-month price target of $196, about 18% above the current price, highlighting catalysts like advisory strength, IPO prospects, and AI advancements. UBS also noted Morgan Stanley's strategic acquisitions and potential regulatory benefits yet to be priced in. This upgrade signals confidence in Morgan Stanley's ability to outperform peers amid geopolitical and market challenges.
Morgan Stanley reported strong Q2 2026 results, with earnings per share of $3.46 surpassing estimates of $2.89 and revenue of $21.35 billion beating forecasts of $19.67 billion. This marks significant year-over-year growth from $16.79 billion, driven...
Morgan Stanley reported strong Q2 results with earnings per share up 63% year-over-year and tangible book value per share increasing to $53.18. Total revenue grew 4% quarter-over-quarter to $21.35 billion, while operating expenses rose only 3%, helpi...
Morgan Stanley reported record revenue of $21.35 billion and earnings per share of $3.46 for Q2, surpassing analyst expectations. The bank saw strong performance across institutional securities, wealth management, and investment management, with net ...
Morgan Stanley reported impressive Q2 earnings, fueled by growth in wealth management, strong investment banking, and solid capital returns. Recurring fee revenue and increasing assets under management (AUM) contributed to the bank's resilient perfor...
Energy prices cooled in June, easing inflation pressures despite ongoing tensions between the U.S. and Iran near the Strait of Hormuz. Morgan Stanley reported record quarterly revenue and profit, boosted by a surge in equities trading fueled by the A...
